Head-to-Head Superiority (SURMOUNT-5): The SURMOUNT-5 trial, with detailed results published in The New England Journal of Medicine on May 11, 2025, directly compared Tirzepatide (Zepbound) with semaglutide (Wegovy)
Konopleva M, Estrov Z, Monaco G, Tsao T, Cardoso A, Leysath C, Xie Z, Zhao S, Belmont J, Sporn M, Andreeff M
-1
rather, the physiological changes that come with significant weight loss including nutrient shifts and the metabolic stress on the body are what push follicles into the resting phase
The convenience of semaglutide telehealth means you can begin your weight loss journey from the comfort of your home, prioritizing your health without lengthy wait times